- Home
- TSVT vs GDO Comparison
TSVT vs GDO Comparison
Compare TSVT & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- GDO
- Stock Information
- Founded
- TSVT 2021
- GDO 2009
- Country
- TSVT United States
- GDO United States
- Employees
- TSVT N/A
- GDO N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- GDO Finance Companies
- Sector
- TSVT Health Care
- GDO Finance
- Exchange
- TSVT Nasdaq
- GDO Nasdaq
- Market Cap
- TSVT 160.4M
- GDO 182.8M
- IPO Year
- TSVT N/A
- GDO N/A
- Fundamental
- Price
- TSVT $3.16
- GDO $11.50
- Analyst Decision
- TSVT Buy
- GDO
- Analyst Count
- TSVT 6
- GDO 0
- Target Price
- TSVT $10.40
- GDO N/A
- AVG Volume (30 Days)
- TSVT 339.4K
- GDO 39.4K
- Earning Date
- TSVT 11-12-2024
- GDO 01-01-0001
- Dividend Yield
- TSVT N/A
- GDO 9.81%
- EPS Growth
- TSVT N/A
- GDO N/A
- EPS
- TSVT N/A
- GDO N/A
- Revenue
- TSVT $45,620,000.00
- GDO N/A
- Revenue This Year
- TSVT N/A
- GDO N/A
- Revenue Next Year
- TSVT $31.98
- GDO N/A
- P/E Ratio
- TSVT N/A
- GDO N/A
- Revenue Growth
- TSVT N/A
- GDO N/A
- 52 Week Low
- TSVT $1.68
- GDO $11.21
- 52 Week High
- TSVT $6.40
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- TSVT 24.53
- GDO 25.46
- Support Level
- TSVT $4.81
- GDO $11.65
- Resistance Level
- TSVT $5.12
- GDO $11.83
- Average True Range (ATR)
- TSVT 0.31
- GDO 0.11
- MACD
- TSVT -0.16
- GDO -0.01
- Stochastic Oscillator
- TSVT 6.67
- GDO 1.49
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.